Preventing Recurrent Clostridioides difficile Infections with Fecal Microbiota-Based Therapies : Episode 12
Administration of FDA-Approved Fecal Microbiota Transplants for C. difficile Infections in Clinical Practice
Matthew D. Sims, MD, PhD, FACP, FIDSA, discusses how fecal microbiota transplantation therapies are administered and shares his clinical experience.
Video content above is prompted by the following:
- How are these FMT therapies administered?
- What has your experience been with administering each of these therapies?
- What have you heard from your patients?
Recent Videos
Related Content
